The cancer testing company announced it has received FDA approval for a higher-throughput, lower-cost Shield workflow.
Guardant Health Q2 Revenues Rise 44 Percent…
The cancer testing company announced it has received FDA approval for a higher-throughput, lower-cost Shield workflow.